Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials
- 2020年03月19日 20:45:00
- テクノロジー
- JCN Newswire
Avance Clinical offers 20-years of experience in the CRO sector, and has conducted vaccine and infectious diseases trials in the past 5 years. Avance is clearly the CRO of choice for trials targeting COVID-19.
"Importantly, the more than 40% R&D cash rebate from the Australian Government and the attractive current exchange rate, makes Australia one the most cost-effective destinations for conducting clinical trials,"said Avance Clinical CEO Yvonne Lungershausen.
Australia's reputation for scientific and research excellence, its advanced healthcare, and the opportunity to access patients in a less clinical trial competitive environment further reinforces its advantage as a destination for current COVID-19 trials.
"Our depth of expertise and knowledge in the area makes us the CRO of choice for any biotech looking to develop treatments for COVID-19,"said Ben Edwards, Avance's Chief Strategy Officer.
"It is also very important to emphasise that based on current trends, Australia is likely to be one of the countries least affected by COVID-19.
We anticipate that this sets the scene for the least amount of disruption to clinical trial activities over the period in which the world adjusts to the situation created by COVID-19."
Ms Lungershausen said in general terms, we do not anticipate significant disruption to the progress and timelines for the projects we are currently managing across all therapeutics indications. "Our team's experience in working with remotely based clients and clinical service providers and our virtual communication systems and processes place us in a clear position of strength in maintaining the momentum for our current projects,"she said.
"Our team is very much accustomed to remote communication and management of projects,"said Mr Edwards.
Clinical research sites in Australia have already responded to the challenges of the COVID-19 pandemic, putting measures and systems in place which aim to safeguard the interests of their patients and the general public, while also seeking to minimise disruption to clinical research activities.
The Avance Clinical operations team maintains constant communication with trial sites, receiving the latest information on ongoing changes in procedures and effectively managing the activities relating to the projects being managed by Avance.
"Avance Clinical has a range of tools available to support the sites and our clients to successfully complete their trials during this challenging time. These will be carefully managed to ensure study compliance,"said Ms Lungershausen.
For more information about the benefits of running your next study in Australia contact us: https://www.avancecro.com/contact-us/
About Avance Clinical
Avance Clinical has more than 20-years of experience and is now one of Australia's leading Contract Research Organisations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialised patient groups. Other benefits include:
- Access to independent Phase 1 facilities across Australia including hospital-based units for critical care
- Dedicated Investigators committed to clinical research
- Major hospitals with world class infrastructures and dedicated Clinical Trial Units
- Expedited clinical trial start-up timeframes
Media Contact:
Media@AvanceCRO.com
Chris Thompson
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
NHK25年前期朝ドラ「あんぱん」柳井嵩役を発表 ヒロイン演じる今田美桜も出席
【U23アジア杯】五輪出場を逃した韓国「欧州組3人を呼べず」約束ほご?にコーチ恨み節
ドランクドラゴン鈴木拓、ウエストランド河本太に“ギャラ折半”解消の先輩として助言
高知東生「子供は親の所有物じゃない。全く別の人格」大阪府知事の「0歳児選挙権」案に私見
元横綱朝青龍が緊急入院から退院報告、手術成功を報告も病名には触れず
「『死にかけた』と言っていた」山本由伸の投手強襲スーパーキャッチ、ロバーツ監督やり取り明かす
遠野なぎこ、“ナンパ”に自粛求める「どれだけ恐怖を感じるか少し立ち止まって考えて頂きたい」
Zeebra「ヒップホップ=金儲け」に異論「第一世代では大成功してる人を探す方が難しい」
カズレーザー「GWまとめて休む文化なくなる」「休みを散らすしかない」国内施設の宿泊費高騰
木村拓哉、Believe初回拡大SP11・7% 激動に巻き込まれる狩山の希望と再生の道とは
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
完全にダマされた! 『ラヴィット!』あのちゃん“事故レベル”大暴走は『水ダウ』遠隔操作のしわざだった ネットも納得
小澤征悦と再婚した桑子真帆アナ(34)黒い過去が流出、衝撃の過去にネット騒然
大原櫻子、ガーシー暴露後初のSNS投稿に賛否の声「イメージ最悪になった」
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
30キロ減量の華原朋美、痩せた美貌で“ノリノリ動画”公開 美ボディーで熱唱
辞退表明の元モー娘。市井氏が「初当選」 1日で辞職も7万円支給へ
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
大久保佳代子「30代前半は性欲おばけ」“ストッパー”にするためあえてしていたこと明かす
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
曙と熱愛した相原勇(52)の現在が衝撃的すぎると話題に
深夜のファミリーマート徘徊、必ず入っている「フエラムネのミニチュアおもちゃ付」を探し求めた結果……
ガーシー、佐野ひなこの暴露を示唆でネット騒然「ファンだったのに」
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
いなば食品のホームページが表示されない!そして「プレスリリース」もヤバすぎると話題に
完全にダマされた! 『ラヴィット!』あのちゃん“事故レベル”大暴走は『水ダウ』遠隔操作のしわざだった ネットも納得
小澤征悦と再婚した桑子真帆アナ(34)黒い過去が流出、衝撃の過去にネット騒然
NHK25年前期朝ドラ「あんぱん」柳井嵩役を発表 ヒロイン演じる今田美桜も出席
【U23アジア杯】五輪出場を逃した韓国「欧州組3人を呼べず」約束ほご?にコーチ恨み節
ドランクドラゴン鈴木拓、ウエストランド河本太に“ギャラ折半”解消の先輩として助言
高知東生「子供は親の所有物じゃない。全く別の人格」大阪府知事の「0歳児選挙権」案に私見
元横綱朝青龍が緊急入院から退院報告、手術成功を報告も病名には触れず
「『死にかけた』と言っていた」山本由伸の投手強襲スーパーキャッチ、ロバーツ監督やり取り明かす
遠野なぎこ、“ナンパ”に自粛求める「どれだけ恐怖を感じるか少し立ち止まって考えて頂きたい」
Zeebra「ヒップホップ=金儲け」に異論「第一世代では大成功してる人を探す方が難しい」
カズレーザー「GWまとめて休む文化なくなる」「休みを散らすしかない」国内施設の宿泊費高騰
木村拓哉、Believe初回拡大SP11・7% 激動に巻き込まれる狩山の希望と再生の道とは